ISSCR News


The ISSCR Launches New Continuing Education Course on Stem Cell Therapies for Parkinson’s Disease
Press Release Kym Kilbourne Press Release Kym Kilbourne

The ISSCR Launches New Continuing Education Course on Stem Cell Therapies for Parkinson’s Disease

‍The International Society for Stem Cell Research (ISSCR) today announced the launch of Stem Cell Medicine: Parkinson’s Disease, a new continuing education course designed to equip clinicians with an evidence-based understanding of emerging stem cell therapies for Parkinson’s disease (PD).

Building on the success of the Society’s inaugural course, Stem Cell Medicine: From Scientific Research to Patient Care, this disease-focused program provides physicians and other healthcare professionals with deeper insight into how advances in stem cell science are moving toward clinical application in one of the most intensively studied neurological disorders.

Read More
Cloaked Stem Cells Evade Immune Rejection in Mice, Pointing to a Potential Universal Donor Cell Line
Press Release Kym Kilbourne Press Release Kym Kilbourne

Cloaked Stem Cells Evade Immune Rejection in Mice, Pointing to a Potential Universal Donor Cell Line

study published today in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can overcome immune rejection in mice with humanized immune systems, surviving for five months in a stringent transplantation model. The findings provide proof-of-principle for the development of a potential universal donor hPSC line designed to resist immune attack.

Read More
The ISSCR Honors Alexander Meissner with the 2026 ISSCR Momentum Award for Exceptional Work in Developmental and Stem Cell Epigenetics
Press Release Kym Kilbourne Press Release Kym Kilbourne

The ISSCR Honors Alexander Meissner with the 2026 ISSCR Momentum Award for Exceptional Work in Developmental and Stem Cell Epigenetics

The International Society for Stem Cell Research (ISSCR) is pleased to announce that Alexander Meissner, Director at the Max Planck Institute for Molecular Genetics, Germany, has been named the recipient of the 2026 ISSCR Momentum Award. The award, supported by BlueRock Therapeutics, recognizes an investigator whose sustained scientific contributions continue to shape and accelerate the field of stem cell research. Dr. Meissner will present his work during ISSCR 2026 taking place in Montréal, Canada on 8-11 July 2026.

Read More
The ISSCR Honors Stem Cell COREdinates and CorEUstem with the 2026 ISSCR Public Service Award
Press Release Kym Kilbourne Press Release Kym Kilbourne

The ISSCR Honors Stem Cell COREdinates and CorEUstem with the 2026 ISSCR Public Service Award

Global Networks Recognized for Transforming Collaboration, Advancing Standards, and Expanding Equitable Access in Stem Cell Science

The International Society for Stem Cell Research (ISSCR) is pleased to announce Stem Cell COREdinates and CorEUstem as the recipients of the 2026 ISSCR Public Service Award. Together, these two global networks represent the world’s leading stem cell core facility consortia, uniting 79 core facilities across continents to advance collaboration, rigor, inclusivity, and innovation in pluripotent stem cell research.

Read More

Receive ISSCR Press Releases

Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications

Subscribe to ISSCR News.

Each month, ISSCR delivers scientific, policy, and community to your inbox .